Safety and efficacy of pembrolizumab combined with paclitaxel and cisplatin as a neoadjuvant treatment for locally advanced resectable (stage III) esophageal squamous cell carcinoma (Keystone-001): Interim analysis of a prospective, single-arm, single-center, phase II trial

被引：15
|
作者：
Shang, X. [1 ]
Zhang, C. [1 ]
Zhao, G. [2 ]
Zhang, W. [3 ]
Liu, L. [3 ]
Duan, X. [1 ]
Yue, J. [1 ]
Ma, Z. [1 ]
Chen, C. [1 ]
Meng, B. [2 ]
Ren, X. [3 ]
Jiang, H. [1 ]
机构：
[1] Tianjin Med Univ, Canc Inst & Hosp, Dept Minimally Invas Esophageal Surg, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China
[3] Tianjin Med Univ, Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA3
引用
收藏
页码：S1428 / S1429
页数：2
相关论文
共 50 条
  • [41] Update results of anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial
    Zhang, Y-F.
    Li, X-B.
    Hong, Y-G.
    Li, X-M.
    Liang, W-M.
    Zheng, Z-X.
    Yang, G-Y.
    Wen, Y-Y.
    Cao, H.
    Wu, W-L.
    Su, W-Z.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1120 - S1120
  • [42] Sintilimab combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma: A single-arm, multicenter, phase 2 trial
    Lyu, Jiahua
    Li, Tao
    Liang, Long
    Li, Churong
    Jia, Hongyuan
    Qi, Yunxiang
    Zheng, Xiumei
    Fan, Yu
    Kuang, Hao
    Bai, Hansong
    Zhang, Wanli
    Lu, Guangbing
    Wang, Gan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Sintilimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Single-Arm, Multicenter, Phase 2 Trial
    Lv, J.
    Liang, L.
    Li, C.
    Jia, H.
    Xiang, Q.
    Zheng, X.
    Fan, Y.
    Kuang, H.
    Bai, H. S.
    Zhang, W.
    Lu, G.
    Wang, G.
    Li, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E467 - E468
  • [44] Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial
    Yan, Jing
    Wang, Kong-cheng
    Yang, Mi
    Gu, Ya-Jun
    Huang, Bin
    Zhu, Yahui
    Sha, Hui-zi
    Zhu, Jing
    Zhu, Chan
    Chen, Dong-sheng
    Qian, Xiao-Yun
    Shen, Xiao-hui
    Chen, Hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] The efficacy and safety of anlotinib in neoadjuvant treatment in locally advanced thyroid cancer: A single-arm phase II clinical trial.
    Huang, Naisi
    Sun, Guohua
    Wang, Yulong
    Chen, Jiaying
    Guan, Qing
    Lu, Zhongwu
    Xiang, Jun
    Wei, Wenjun
    Ma, Ben
    Ji, Qinghai
    Wang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
    Zhang, Zhanjie
    Wu, Bian
    Peng, Gang
    Xiao, Guixiang
    Huang, Jing
    Ding, Qian
    Yang, Chengzhang
    Xiong, Xingao
    Ma, Hui
    Shi, Liangliang
    Yang, Jinsong
    Hong, Xiaohua
    Wei, Jielin
    Qin, You
    Wan, Chao
    Zhong, Yi
    Zhou, Yan
    Zhao, Xueyan
    Leng, Yangming
    Zhang, Tao
    Wu, Gang
    Yao, Min
    Zhang, Xiaomeng
    Yang, Kunyu
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3268 - 3276
  • [47] A single-arm, multicenter, phase II clinical study of tislelizumab plus albumin-bound paclitaxel/cisplatin as neoadjuvant therapy for borderline resectable esophageal squamous cell carcinoma
    Li, Xiaodong
    Xu, Congcong
    Qiu, Hongbin
    Chen, Dong
    Zhu, Kanghao
    Zhang, Bo
    Zhang, Jian
    Xu, Anyi
    Wang, Chunguo
    Shen, Jianfei
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (05)
  • [48] Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
    Guo, Jhe-Cyuan
    Huang, Ta-Chen
    Kuo, Hung-Yang
    Lin, Chia-Chi
    Hsu, Feng-Ming
    Cheng, Jason Chia-Hsien
    Huang, Yen-Lin
    Hsieh, Min-Shu
    Huang, Pei-Ming
    Lee, Jang-Ming
    Wu, Shu-Ling
    Hsu, Chih-Hung
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (11)
  • [49] NEOADJUVANT TORIPALIMAB COMBINED WITH AXITINIB IN PATIENTS WITH LOCALLY ADVANCED CLEAR CELL RENAL CELL CARCINOMA: A SINGLE-ARM, PHASE II TRIAL
    Huang, Jiwei
    JOURNAL OF UROLOGY, 2024, 211 (05): : E712 - E713
  • [50] Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
    Huang, Jiwei
    Wang, Yueming
    Xu, Fan
    Wang, Zaoyu
    Wu, Guangyu
    Kong, Wen
    Cheoklong, Ng
    Tricard, Thibault
    Wu, Xiaorong
    Zhai, Wei
    Zhang, Wei
    Zhang, Jiyang
    Zhang, Ding
    Chen, Shuyin
    Lian, Yuqing
    Chen, Yonghui
    Zhang, Jin
    Huang, Yiran
    Xue, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
12345